| Title | Author(s) | Year | View Count |
 | Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis | Mok, CC; Ying, KY; Tang, S; Leung, CY; Lee, KW; Ng, WL; Wong, RWS; Lau, CS | 2004 | 128 |
 | Antiphospholipid (aPL) antibody profiles in Chinese patients with systemic lupus erythematosus | Mok, TMY; Chan, EYT; Leung, K; Lo, Y; Wong, RWS; Lau, CS | 2004 | 169 |
 | Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis | Mok, CC; Ying, KY; Tang, SCW; Leung, CY; Lee, KW; Ng, WL; Wong, RWS; Lau, WCS | 2004 | 94 |
| Efficacy of chemoprophylaxis for tuberculosis infection in patients with systemic lupus erythematosus in an endemic area | Mok, TMY; Lo, Y; Chan, DTM; Wong, RWS; Lau, WCS | 2003 | 187 |
| Use of health status measurement scales among arthritis patients with low educational level | Chu, EMY; Chiu, PKY; Wong, RWS; Lau, WCS | 2003 | 146 |
| Treatment of severe proliferative lupus nephritis: The current state | Mok, CC; Wong, RWS; Lai, KN | 2003 | 174 |
| Efficacy of chemotherapy for tuberculosis infection in patients with systemic lupus erythematosus in an endemic area | Mok, TMY; Lo, Y; Chan, DTM; Wong, RWS; Lau, WCS | 2003 | 69 |
| Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: An open-label study | Mok, CC; Lau, CS; Wong, RWS | 2003 | 37 |
| Damage accrual in southern Chinese patients with systemic lupus erythematosus | Mok, CC; Ho, CTK; Wong, RWS; Lau, CS | 2003 | 46 |
| Efficacy of isoniazid chemoprophylaxis for tuberculous infection in patients with systemic lupus erythematosus | Mok, TMY; Lo, Y; Chan, DTM; Wong, RWS; Lau, WCS | 2003 | 63 |
| Interstitial lung disease in systemic sclerosis: An HRCT-clinical correlative study | Ooi, GC; Mok, MY; Tsang, KWT; Wong, Y; Khong, PL; Fung, PCW; Chan, S; Tse, HF; Wong, RWS; Lam, WK; Lau, CS | 2003 | 95 |
| Efficacy of Isoniazid Chemoprophylaxis for Tuberculous Infection in Patients with systemic Lupus Erythematosus | Mok, MY; Lo, Y; Chan, DTM; Wong, RWS; Lau, WCS | 2002 | 66 |
| Outcome and prognostic indicators of diffuse proliferative lupus glomerulonephritis treated with sequential oral cyclosphamide and azathioprine | Mok, CC; Ho, CTK; Chan, KW; Lau, WCS; Wong, RWS | 2002 | 104 |
| Behçet's disease in southern Chinese patients | Mok, CC; Cheung, TC; Ho, CTK; Lee, KW; Lau, CS; Wong, RWS | 2002 | 42 |
| Lymphoepithelioma-like carcinoma of the parotid gland in a patient with rheumatoid arthritis | Mok, MY; Shek, WH; Wong, RWS | 2002 | 49 |
| Efficacy of Isoniazid chemoprophylaxis for Tuberculous Infection in Patients with Systemic Lupus Erythematosus | Mok, MY; Lo, Y; Chan, DTM; Wong, RWS; Lau, WCS | 2002 | 61 |
| Neuropsychiatric manifestations in southern Chinese patients with systemic lupus erythematosus (SLE) according to the 1999 ACR nomenclature and their clinical associations | Mok, CC; Lau, WCS; Wong, RWS | 2001 | 150 |
| Validity and reliability of a Chinese version of the arthritis impact measurement scales 2 (CAIMS2) | Chu, EMY; Chiu, PKY; Wong, RWS; Lau, WCS | 2001 | 212 |
| ACR/SLICC damage scores in an inception cohort of patients with systemic lupus erythematosus (SLE) and their relationship with disease flares and various clinical variables | Ho, CTK; Mok, CC; Wong, RWS; Lau, WCS | 2001 | 241 |
| Exhaled and serum nitric oxide measurement in patients with systemic sclerosis complicated by interstitial lung involvement | Mok, MY; Wong, WY; Ooi, CGC; Lam, YM; Tse, HF; Chan, S; Tsang, KWT; Fung, PCW; Wong, RWS; Lau, WCS | 2001 | 290 |
|
